Since MALAT1 did not have covariance with significant prognostic factors including size of tumor, number of tumors, tumor stage, and gender, we constructed prediction models for progression rate and survival rate based on MALAT1 and those factors. The gene discussed is MALAT1; the disease is neoplasm.